Results for tag: "Lassa Drug"

The Lassa Drug market is a subset of the Infectious Diseases Drugs market, focusing on drugs used to treat Lassa fever, a viral hemorrhagic fever endemic to West Africa. Lassa fever is caused by the Lassa virus, which is spread through contact with infected rodents and their excreta. The Lassa Drug market is composed of drugs used to treat the symptoms of Lassa fever, as well as drugs used to prevent the spread of the virus. These drugs are typically administered in the form of antivirals, antimalarials, and antibiotics. The Lassa Drug market is composed of a variety of companies, including pharmaceutical companies, biotechnology companies, and research institutions. Some of the major players in the market include GlaxoSmithKline, Merck & Co., Sanofi, Johnson & Johnson, and the World Health Organization. Show Less Read more